Published in Scand J Infect Dis on January 01, 1988
Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis (1999) 0.99
Human antibody response to fragments A and B of diphtheria toxin and a synthetic peptide of amino acid residues 141-157 of fragment A. Epidemiol Infect (1990) 0.86
Immunity against diphtheria in adults in Poland. Epidemiol Infect (1989) 0.83
Evaluation of antidiphtheria toxin nanobodies. Nanotechnol Sci Appl (2010) 0.79
Immunity to diphtheria and tetanus among blood donors in Arak, central province of Iran. Iran J Microbiol (2014) 0.77
Immunity to diphtheria in a sample of the Canadian adult population. Can J Infect Dis (1998) 0.75
No influence of atopic diseases on antibody titres following tetanus, diphtheria and hepatitis B immunisation among adults. Eur J Clin Microbiol Infect Dis (2007) 0.75
Serological survey on the immunity to diphtheria of the northern Greek population. Eur J Epidemiol (1997) 0.75
Immunity to diphtheria in Izmir, Turkey. Eur J Epidemiol (2000) 0.75
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest (1985) 1.81
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand (1985) 1.65
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int (2001) 1.21
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Volvulus of the sigmoid colon in Brazil: a report of 230 cases. Dis Colon Rectum (1976) 1.05
Prevention of postoperative deep venous thrombosis. Low-dose heparin versus graded pressure stockings. Acta Chir Scand (1985) 1.05
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol (1993) 0.96
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Can DXA predict fractures in renal transplant patients? Am J Transplant (2008) 0.95
Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet (1985) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
A long-term follow-up of the effect of repeated corticosteroid injections for stenosing tenovaginitis. J Hand Surg Br (1989) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int (1997) 0.88
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Altered timing of hamstring muscle action in anterior cruciate ligament deficient patients. Am J Sports Med (1990) 0.88
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
Muscle coordination following rupture of the anterior cruciate ligament. Electromyographic studies of 14 patients. Acta Orthop Scand (1991) 0.88
Cardiovascular effects of epinephrine during rewarming from hypothermia in an intact animal model. J Appl Physiol (1985) (2005) 0.87
The accuracy of clinical examination of injury of the knee joint. Injury (1984) 0.87
Chyluria treated with renal autotransplantation: a case report. J Urol (1990) 0.87
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg (1997) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
Is the acute encephalopathy test in mice suited for control of pertussis vaccines? Dev Biol Stand (1985) 0.86
A cluster of Legionnaires disease linked to an industrial plant in southeast Norway, June-July 2008. Euro Surveill (2008) 0.85
Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.85
Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro. Clin Exp Immunol (1981) 0.85
Displaced forearm fractures in children treated with AO plates. Injury (1984) 0.85
Negative effect of Metoclopramide in postoperative adynamic ileus. A prospective, randomized, double blind study. Br J Surg (1986) 0.84
Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivity. FEMS Microbiol Lett (1995) 0.84
Arthroscopy in acute knee injuries. Acta Orthop Scand (1986) 0.83
[Experimental and clinical study on the use as a transplant of homogenous dura mater preserved in glycerin at room temperature]. AMB Rev Assoc Med Bras (1971) 0.83
Stimulation of human lymphocytes by cytomegalovirions and dense bodies. Med Microbiol Immunol (1978) 0.83
Video based analysis of dynamic midfoot function and its relationship with Foot Posture Index scores. Gait Posture (2009) 0.82
Occurrence of cytotoxic antibodies during pregnancy. Vox Sang (1971) 0.82
Proliferative response to seven affinity purified mycobacterial antigens in eight strains of inbred mice. Int J Lepr Other Mycobact Dis (1991) 0.82
Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine. Scand J Infect Dis (1999) 0.82
13 native human interferon-alpha species assessed for immunoregulatory properties. J Interferon Res (1983) 0.82
Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine (1995) 0.82
A paraffin embedding method in kidney immunofluorescent studies. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 0.82
Identification of human T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1992) 0.82
Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Vaccine (1998) 0.81
Vancomycin and netilmicin as first line treatment of peritonitis in CAPD patients. J Antimicrob Chemother (1985) 0.81
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. Leukemia (1995) 0.81